Chicago Partners Investment Group
NVCR icon

Chicago Partners Investment Group’s NovoCure NVCR Stock Holding History

Chicago Partners Investment Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$614K Buy
30,730
+10,629
+53% +$161K 0.01% 875
2026
Q1 		$262K Sell
20,101
-4,334
-18% -$54.1K 0.01% 1212
2025
Q4 		$329K Buy
24,435
+4,255
+21% +$54.6K 0.01% 979
2025
Q3 		$270K Buy
20,180
+4,229
+27% +$56.5K 0.01% 1011
2025
Q2 		$263K Buy
+15,951
New +$278K 0.01% 910

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Chicago Partners Investment Group's NVCR Position: Q2 2026 in Review

Chicago Partners Investment Group increased its NovoCure (NVCR) stake by 53% in Q2 2026, buying an estimated $161K and bringing the position to 30,730 shares worth $614K. The position accounts for 0.01% of the portfolio, ranked #875.

Chicago Partners Investment Group first reported a position in NVCR in Q2 2025 and has held it in 5 quarters since. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Chicago Partners Investment Group held 30,730 shares of NovoCure worth $614K as of Q2 2026.
  • Chicago Partners Investment Group bought 10,629 NovoCure shares in Q2 2026, an estimated $161K.
  • NovoCure made up 0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #875 holding.
  • Chicago Partners Investment Group first reported a position in NovoCure in Q2 2025 and has held it in 5 quarters since.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.